The effect of comorbidities and respiratory symptoms on healthcare costs in patients with COPD. Results from the COSYCONET cohort
ME Wacker, RA Jörres, H Schulz, J Heinrich, S Karrasch, A Karch, A Koch, R Leidl, C Vogelmeier, R Holle · Pneumologie · 2016 · Heft 07
Bibliografische Angaben
Zusammenfassung
Background: Healthcare costs in patients with COPD are rising with increasing disease severity. This study investigates the role of comorbidities and symptoms as additional drivers of costs based on data from the COSYCONET COPD cohort. Methods: Healthcare costs for the year 2012 were calculated from self-reported data on healthcare utilization from the baseline examination of patients with physician-diagnosed COPD in GOLD grade 1 – 4. From a list of 33 possible self-reported comorbidities, 26 with a prevalence > 3% and information on cough, dyspnea (mMRC grade), and sputum were used as predictors of costs in gen…
